Imagine discovering that the very formula meant to nourish your baby could be silently harming them. This is the chilling reality for over 50 families across 19 states, as a botulism outbreak linked to ByHeart baby formula continues to unfold. But here's where it gets even more alarming: federal health officials now suspect that every single batch of ByHeart formula produced since March 2022 might be contaminated. This isn't just a minor recall—it's a full-blown investigation that has parents, doctors, and regulators on high alert.
On December 11, 2025, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) expanded their probe into the outbreak, which was first announced on November 8. The official tally now stands at at least 51 infants in states ranging from California to Texas, with the most recent case reported on December 1. While no deaths have been reported, the emotional and physical toll on these families is undeniable.
But here’s the part most people miss: This isn’t ByHeart’s first brush with contamination. In 2022, the company recalled five batches of formula due to cronobacter sakazakii, and in 2023, the FDA issued a warning letter citing ongoing issues. A Pennsylvania plant was even shut down after inspectors found mold, water leaks, and insects. So, the question lingers: How did this keep happening, and why wasn’t it caught sooner?
For parents like Andi Galindo, whose 5-week-old daughter Rowan was hospitalized with botulism in December 2023, the news is devastating. Galindo had chosen ByHeart based on a lactation consultant’s recommendation, trusting it was “very natural, very gentle, very good for babies.” Now, she’s demanding accountability: “If there’s proof of issues from the beginning, they need to be held accountable.”
Amy Mazziotti, another affected parent, feels a mix of relief and anger. Her son Hank fell ill in March 2024 after drinking ByHeart formula. “I’ve known in my gut it was the formula,” she said. “Seeing these cases finally recognized brings tears to my eyes—relief, gratitude, and hope that the truth is out.”
But here’s where it gets controversial: ByHeart, which controls just 1% of the U.S. infant formula market, has been cooperative with investigators, but the scope of the contamination raises serious questions about their quality control. Independent lab tests found botulism-causing bacteria in 36 samples across three different lots, and the FDA’s inspections of plants in Iowa and Oregon have yet to yield public results. Could this have been prevented with stricter oversight? And should parents trust any formula brand moving forward?
Infant botulism is rare, affecting fewer than 200 babies in the U.S. annually. It occurs when infants ingest botulism spores that germinate in their intestines, producing a toxin that attacks the nervous system. Symptoms, which can take up to 30 days to appear, include constipation, poor feeding, loss of head control, drooping eyelids, and a flat facial expression. The only treatment is BabyBIG, an IV medication derived from the blood plasma of adults immunized against botulism.
And this is the part that’s truly unsettling: This is the first confirmed outbreak of infant botulism tied to powdered formula, according to research. While sporadic cases have occurred, never before has an entire brand been under such scrutiny. Families are now suing ByHeart, alleging negligence and seeking compensation for medical bills, emotional distress, and more.
As the investigation continues, one thing is clear: this isn’t just about ByHeart—it’s about the trust parents place in the products they use to care for their children. What do you think? Should there be stricter regulations for formula manufacturers? Or is this an isolated incident that could happen to any brand? Share your thoughts in the comments—this conversation needs your voice.
